SCHEMBL25868621

SCHEMBL25868621

CN(C)CCC(=O)OCCC(=O)NN(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM7A Q6ZMT4 1/20 0.46
PHF8 Q9UPP1 1/20 0.46
KDM2A Q9Y2K7 1/20 0.46
DNM1 Q05193 1/20 0.45
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRM3 P20309 1/20 0.37
CHRNA4 P43681 1/20 0.37
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADRA2A P08913 1/20 0.34
ADRA1A P35348 1/20 0.34
BLM P54132 2/20 0.33
MAPT P10636 1/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25393813 0.86 DNM1 (0.53) KDM7APHF8KDM2ADNM1MEN1
SCHEMBL8747962 0.80 KDM7A (0.60) KDM7APHF8KDM2ADNM1MEN1
SCHEMBL11668491 0.78 DNM1 (0.66) DNM1MEN1KMT2ACHRM2CHRM4
SCHEMBL25868589 0.78 KDM7A (0.48) KDM7APHF8KDM2ADNM1MEN1
SCHEMBL16154783 0.76 DNM1 (0.68) DNM1TSHRALDH1A1NAAADGKA
SCHEMBL22460827 0.75 DNM1 (0.52) DNM1MEN1KMT2ACHRM2CHRM4
SCHEMBL16023900 0.75 DNM1 (0.61) DNM1MEN1KMT2ACHRM2CHRM4
Hydrochloric Acid SCHEMBL11841630 0.73 DNM1 (0.59) DNM1MEN1KMT2ACHRM2CHRM4
SCHEMBL6403497 0.73 DNM1 (0.74) DNM1NAAADGKATHRBTHRA
SCHEMBL3038090 0.72 DNM1 (0.68) DNM1MEN1KMT2ACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023137227-A1 MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO KARMA BIOTECHNOLOGIES (US) 2023-07-20 WO disclosed